Microbial Community Structure and Activity in Trace Element-Contaminated Soils (Phyto)Managed by Gentle Remediation Options (GRO)
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
A New Michaelis Complex Leads to Efficient Transition State Charge Offset
Evolutionary repurposing of a sulfatase: A new Michaelis complex leads to efficient transition state charge offset Charlotte M. Mitona,1, Stefanie Jonasa,2, Gerhard Fischera,3, Fernanda Duarteb,3,4, Mark F. Mohameda, Bert van Looa,5, Bálint Kintsesa,6, Shina C. L. Kamerlinb, Nobuhiko Tokurikia,c, Marko Hyvönena, and Florian Hollfeldera,7 aDepartment of Biochemistry, University of Cambridge, CB2 1GA Cambridge, United Kingdom; bDepartment of Chemistry, Biomedicinskt Centrum (BMC), Uppsala University, 751 23 Uppsala, Sweden; and cMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada Edited by Daniel Herschlag, Stanford University, Stanford, CA, and accepted by Editorial Board Member Michael A. Marletta May 31, 2018 (received for review January 31, 2018) The recruitment and evolutionary optimization of promiscuous catalytic residues but also occurs at the periphery of the catalytic enzymes is key to the rapid adaptation of organisms to changing machinery, even in positions as remote as the second and third environments. Our understanding of the precise mechanisms shells of the active site (23). In studies examining detailed evo- underlying enzyme repurposing is, however, limited: What are lutionary transitions, function-altering mutations led to the dis- the active-site features that enable the molecular recognition of placement of a catalytic metal ion or the repositioning of a multiple substrates with contrasting catalytic requirements? To nucleophile (24–26). In further cases, the position of the catalytic gain insights into the molecular determinants of adaptation in residues remained unaltered, but other structural features, for promiscuous enzymes, we performed the laboratory evolution of an arylsulfatase to improve its initially weak phenylphosphonate Significance hydrolase activity. -
The Classification of Esterases: an Important Gene Family Involved in Insecticide Resistance - a Review
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 107(4): 437-449, June 2012 437 The classification of esterases: an important gene family involved in insecticide resistance - A Review Isabela Reis Montella1,2, Renata Schama1,2,3/+, Denise Valle1,2,3 1Laboratório de Fisiologia e Controle de Artrópodes Vetores, Instituto Oswaldo Cruz-Fiocruz, Av. Brasil 4365, 21040-900 Rio de Janeiro, RJ, Brasil 2Instituto de Biologia do Exército, Rio de Janeiro, RJ, Brasil 3Instituto Nacional de Ciência e Tecnologia em Entomologia Molecular, Rio de Janeiro, RJ, Brasil The use of chemical insecticides continues to play a major role in the control of disease vector populations, which is leading to the global dissemination of insecticide resistance. A greater capacity to detoxify insecticides, due to an increase in the expression or activity of three major enzyme families, also known as metabolic resistance, is one major resistance mechanisms. The esterase family of enzymes hydrolyse ester bonds, which are present in a wide range of insecticides; therefore, these enzymes may be involved in resistance to the main chemicals employed in control programs. Historically, insecticide resistance has driven research on insect esterases and schemes for their classification. Currently, several different nomenclatures are used to describe the esterases of distinct species and a universal standard classification does not exist. The esterase gene family appears to be rapidly evolving and each insect species has a unique complement of detoxification genes with only a few orthologues across species. The examples listed in this review cover different aspects of their biochemical nature. However, they do not appear to contribute to reliably distinguish among the different resistance mechanisms. -
1 Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental
Page 1 of 255 Diabetes Metabolic dysfunction is restricted to the sciatic nerve in experimental diabetic neuropathy Oliver J. Freeman1,2, Richard D. Unwin2,3, Andrew W. Dowsey2,3, Paul Begley2,3, Sumia Ali1, Katherine A. Hollywood2,3, Nitin Rustogi2,3, Rasmus S. Petersen1, Warwick B. Dunn2,3†, Garth J.S. Cooper2,3,4,5* & Natalie J. Gardiner1* 1 Faculty of Life Sciences, University of Manchester, UK 2 Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK 3 Centre for Endocrinology and Diabetes, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, UK 4 School of Biological Sciences, University of Auckland, New Zealand 5 Department of Pharmacology, Medical Sciences Division, University of Oxford, UK † Present address: School of Biosciences, University of Birmingham, UK *Joint corresponding authors: Natalie J. Gardiner and Garth J.S. Cooper Email: [email protected]; [email protected] Address: University of Manchester, AV Hill Building, Oxford Road, Manchester, M13 9PT, United Kingdom Telephone: +44 161 275 5768; +44 161 701 0240 Word count: 4,490 Number of tables: 1, Number of figures: 6 Running title: Metabolic dysfunction in diabetic neuropathy 1 Diabetes Publish Ahead of Print, published online October 15, 2015 Diabetes Page 2 of 255 Abstract High glucose levels in the peripheral nervous system (PNS) have been implicated in the pathogenesis of diabetic neuropathy (DN). However our understanding of the molecular mechanisms which cause the marked distal pathology is incomplete. Here we performed a comprehensive, system-wide analysis of the PNS of a rodent model of DN. -
Exploring the Microbiome of the Mediterranean Sponge Aplysina Aerophoba by Single-Cell and Metagenomics
Exploring the microbiome of the Mediterranean sponge Aplysina aerophoba by single-cell and metagenomics Untersuchungen am Mikrobiom des Mittelmeerschwamms Aplysina aerophoba mittels Einzelzell- und Metagenomik Doctoral thesis for a doctoral degree at the Graduate School of Life Sciences Julius-Maximilians-Universität Würzburg Section: Integrative Biology Submitted by Beate Magdalena Slaby from München Würzburg, March 2017 Submitted on: ……………………………………………………… Members of the Promotionskomitee Chairperson: Prof. Dr. Thomas Müller Primary Supervisor: Prof. Dr. Ute Hentschel Humeida Supervisor (Second): Prof. Dr. Thomas Dandekar Supervisor (Third): Prof. Dr. Frédéric Partensky Date of public defense: ……………………………………………………… Date of receipt of certificates: ……………………………………………………… ii Affidavit I hereby confirm that my thesis entitled ‘Exploring the microbiome of the Mediterranean sponge Aplysina aerophoba by single-cell and metagenomics’ is the result of my own work. I did not receive any help or support from commercial consultants. All sources and / or materials applied are listed and specified in the thesis. Furthermore, I confirm that this thesis has not yet been submitted as part of another examination process neither in identical nor in similar form. Place, Date Signature iii Acknowledgements I received financial support for this thesis project by a grant of the German Excellence Initiative to the Graduate School of Life Sciences of the University of Würzburg through a PhD fellowship, and from the SponGES project that has received funding from the European Union’s Horizon 2020 research and innovation program. I would like to thank: Dr. Ute Hentschel Humeida for her support and encouragement, and for providing so many extraordinary opportunities. Dr. Thomas Dandekar and Dr. Frédéric Partensky for the supervision and a number of very helpful discussions. -
The Gene for Albicidin Detoxification from Pantoea Dispersa Encodes An
Proc. Natl. Acad. Sci. USA Vol. 94, pp. 9984–9989, September 1997 Plant Biology The gene for albicidin detoxification from Pantoea dispersa encodes an esterase and attenuates pathogenicity of Xanthomonas albilineans to sugarcane (phytotoxin resistanceyleaf scald diseaseyserine hydrolaseypathogenicity factor) LIANHUI ZHANG* AND ROBERT G. BIRCH Department of Botany, The University of Queensland, Brisbane 4072, Australia Communicated by Allen Kerr, University of Adelaide, Adelaide, Australia, June 16, 1997 (received for review April 4, 1997) ABSTRACT Albicidin phytotoxins are pathogenicity fac- produces a family of antibiotics and phytotoxins that block tors in a devastating disease of sugarcane known as leaf scald, DNA replication in bacteria and sugarcane proplastids (13, caused by Xanthomonas albilineans. A gene (albD) from Pantoea 14). The major toxin, named albicidin, has been partially dispersa has been cloned and sequenced and been shown to characterized as a low Mr compound with several aromatic code for a peptide of 235 amino acids that detoxifies albicidin. rings. Because albicidin is rapidly bactericidal to a range of The gene shows no significant homology at the DNA or protein Gram-positive and Gram-negative bacteria at concentrations level to any known sequence, but the gene product contains a as low as 1 ng ml21, it is also of interest as a potential clinical GxSxG motif that is conserved in serine hydrolases. The AlbD antibiotic (15). protein, purified to homogeneity by means of a glutathione Symptoms of leaf scald disease include the emergence of S-transferase gene fusion system, showed strong esterase chlorotic leaves, wilting, necrosis, and sometimes rapid death activity on p-nitrophenyl butyrate and released hydrophilic of plants, often after a prolonged latent period. -
S. Nagel Et Al., Microarray Analysis of the Global Gene Expression Profile Following Hypothermia and Transient Focal Cerebral Ischemia Neuroscience 2012
S. Nagel et al., Microarray analysis of the global gene expression profile following hypothermia and transient focal cerebral ischemia Neuroscience 2012 Supplementary Table 1 Gene Symbol Entrez Gene Name Affymetrix SNP ID Fold Change PEBP1 phosphatidylethanolamine binding protein 1 E05646cds_s_at 36,571 KIFC1 kinesin family member C1 AF035951_at 29,307 SERP1 stress-associated endoplasmic reticulum protein 1 AF100470_at 23,16 FDXR ferredoxin reductase D63761_g_at 22,504 SYNPO synaptopodin AB013130_at 21,174 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein L23148_g_at 16,233 GTF2F2 general transcription factor IIF, polypeptide 2, 30kDa L01267_at 15,592 PPP2R2C protein phosphatase 2, regulatory subunit B, gamma D38261_at 15,356 RASGRP1 RAS guanyl releasing protein 1 (calcium and DAG-regulated) AF081196_at 15,142 UBB -- D16554_at 14,996 SLC37A4 solute carrier family 37 (glucose-6-phosphate transporter), member 4 AF080468_g_at 14,757 LIMK2 LIM domain kinase 2 D31874_at 14,254 PPP1R15A protein phosphatase 1, regulatory (inhibitor) subunit 15A AF020618_g_at 13,988 HPCAL4 hippocalcin like 4 D13125_at 13,128 FAIM2 Fas apoptotic inhibitory molecule 2 AF044201_at 12,77 GJA5 gap junction protein, alpha 5, 40kDa AF022136_at 12,751 SLC2A3 solute carrier family 2 (facilitated glucose transporter), member 3 D13962_g_at 12,245 TRIM23 tripartite motif containing 23 L04760_at 12,122 PIP4K2C phosphatidylinositol-5-phosphate 4-kinase, type II, gamma AF030558_at 11,698 SBK1 SH3-binding domain kinase 1 AB010154_at 11,523 PLEKHA1 pleckstrin -
N-Acetylgalactosamine-6-Sulfate Sulfatase in Man. Absence of the Enzyme in Morquio Disease
N-acetylgalactosamine-6-sulfate sulfatase in man. Absence of the enzyme in Morquio disease. J Singh, … , P Niebes, D Tavella J Clin Invest. 1976;57(4):1036-1040. https://doi.org/10.1172/JCI108345. Research Article Human N-acetylgalactosamine-6-sulfate sulfatase (6-sulfatase) activity is measured by using as a substrate a sulfated tetrasaccharide obtained by digesting purified chondroitin-6-sulfate (C-6-S) with testicular hyaluronidase. The amount of inorganic sulfate released is measured turbidimetrically. The enzyme from human kidney has a pH optimum of 4.8; its activity is augmented by low levels of NaCl and inhibited by phosphate and high levels of NaCl. Free glucuronate, acetylgalactosamine, inorganic sulfate, polymeric C-6-S, or tetrasaccharide obtained from chondroitin-4-sulfate do not affect the enzyme activity. The method may be used for the diagnosis of Morquio disease since extracts of Morquio fibroblasts are devoid of 6-sulfatase activity. Find the latest version: https://jci.me/108345/pdf N-Acetylgalactosamine-6-Sulfate Sulfatase in Man ABSENCE OF THE ENZYME IN MORQUIO DISEASE JAGAT SINGH, NICOLA Di FERRANTE, PAUL NIEBES, and DANIELA TAVELLA From the Departments of Biochemistry and Medicine, and the Division of Orthopedic Surgery of the Department of Surgery, Baylor College of Medicine, Houston, Texas 77025 and Zyma, S.A., Nyon, Switzerland A B S T R A C T Human N-acetylgalactosamine-6-sulfate measurement, and the need to ascertain whether the sulfatase (6-sulfatase) activity is measured by using as sulfate released was in position 4 or 6 of the galactos- a substrate a sulfated tetrasaccharide obtained by di- amine moieties make the method (1) rather laborious gesting purified chondroitin-6-sulfate (C-6-S) with tes- and not ideal for the routine assay of the enzyme ac- ticular hyaluronidase. -
Protein Network Analyses of Pulmonary Endothelial Cells In
www.nature.com/scientificreports OPEN Protein network analyses of pulmonary endothelial cells in chronic thromboembolic pulmonary hypertension Sarath Babu Nukala1,8,9*, Olga Tura‑Ceide3,4,5,9, Giancarlo Aldini1, Valérie F. E. D. Smolders2,3, Isabel Blanco3,4, Victor I. Peinado3,4, Manuel Castell6, Joan Albert Barber3,4, Alessandra Altomare1, Giovanna Baron1, Marina Carini1, Marta Cascante2,7,9 & Alfonsina D’Amato1,9* Chronic thromboembolic pulmonary hypertension (CTEPH) is a vascular disease characterized by the presence of organized thromboembolic material in pulmonary arteries leading to increased vascular resistance, heart failure and death. Dysfunction of endothelial cells is involved in CTEPH. The present study describes for the frst time the molecular processes underlying endothelial dysfunction in the development of the CTEPH. The advanced analytical approach and the protein network analyses of patient derived CTEPH endothelial cells allowed the quantitation of 3258 proteins. The 673 diferentially regulated proteins were associated with functional and disease protein network modules. The protein network analyses resulted in the characterization of dysregulated pathways associated with endothelial dysfunction, such as mitochondrial dysfunction, oxidative phosphorylation, sirtuin signaling, infammatory response, oxidative stress and fatty acid metabolism related pathways. In addition, the quantifcation of advanced oxidation protein products, total protein carbonyl content, and intracellular reactive oxygen species resulted increased -
Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients with Stable Coronary Heart Disease
Supplementary Online Content Ganz P, Heidecker B, Hveem K, et al. Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease. JAMA. doi: 10.1001/jama.2016.5951 eTable 1. List of 1130 Proteins Measured by Somalogic’s Modified Aptamer-Based Proteomic Assay eTable 2. Coefficients for Weibull Recalibration Model Applied to 9-Protein Model eFigure 1. Median Protein Levels in Derivation and Validation Cohort eTable 3. Coefficients for the Recalibration Model Applied to Refit Framingham eFigure 2. Calibration Plots for the Refit Framingham Model eTable 4. List of 200 Proteins Associated With the Risk of MI, Stroke, Heart Failure, and Death eFigure 3. Hazard Ratios of Lasso Selected Proteins for Primary End Point of MI, Stroke, Heart Failure, and Death eFigure 4. 9-Protein Prognostic Model Hazard Ratios Adjusted for Framingham Variables eFigure 5. 9-Protein Risk Scores by Event Type This supplementary material has been provided by the authors to give readers additional information about their work. Downloaded From: https://jamanetwork.com/ on 10/02/2021 Supplemental Material Table of Contents 1 Study Design and Data Processing ......................................................................................................... 3 2 Table of 1130 Proteins Measured .......................................................................................................... 4 3 Variable Selection and Statistical Modeling ........................................................................................ -
Lab Dept: Chemistry Test Name: ARYLSULFATASE A, LEUKOCYTES
Lab Dept: Chemistry Test Name: ARYLSULFATASE A, LEUKOCYTES General Information Lab Order Codes: ARYL Synonyms: Metachromic Leukodystrophy; Mucolipidoses, Types II and III; ARS-A (Arylsulfatase A); WBC Aryl Sulfatase A CPT Codes: 82657 – Enzyme activity in blood cells, cultured cells, or tissue, not elsewhere specified; nonradioactive substrate Test Includes: Arylsulfatase A, Leukocyte level reported in nmol/h/mg. Logistics Test Indications: Leukocyte assay is the preferred test to order first to rule out metachromatic leukodystrophy. Not reliable in identifying carriers due both to analytical variation and unusual genetic variants. The urine assay should be used in confirming leukocyte results. Lab Testing Sections: Chemistry - Sendouts Referred to: Mayo Medical Laboratories (MML Test: ARSAW) Phone Numbers: MIN Lab: 612-813-6280 STP Lab: 651-220-6550 Test Availability: Daily, 24 hours (Specimen must be received by reference lab within 96 hours of collection and must be received 1 day prior to assay day for processing) Turnaround Time: 8 – 15 days; test set up Tuesday Special Instructions: Specimen must arrive within 48 hours of draw. Obtain special collection tube from the laboratory. Specimen Specimen Type: Whole blood Container: Yellow top (ACD Solution B) tube available from laboratory Alternate: Yellow top (ACD Solution A) Draw Volume: 6 mL (Minimum: 5 mL) ACD Whole blood Processed Volume: Same as Draw Volume Collection: Routine blood collection Special Processing: Lab Staff: Do Not process specimen, leave in original draw container. -
Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders
antioxidants Article Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders Ignazio Stefano Piras 1,2, Stefano Gabriele 1, Laura Altieri 1, Federica Lombardi 1, Roberto Sacco 1, Carla Lintas 1 , Barbara Manzi 3, Paolo Curatolo 3, Maria Nobile 4, Catia Rigoletto 4, Massimo Molteni 4 and Antonio M. Persico 5,* 1 Unit of Child & Adolescent Neuropsychiatry, University Campus Bio-Medico, I-00128 Rome, Italy; [email protected] (I.S.P.); [email protected] (S.G.); [email protected] (L.A.); [email protected] (F.L.); [email protected] (R.S.); [email protected] (C.L.) 2 Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ 85254, USA 3 Unit of Child and Adolescent Neuropsychiatry, University of Rome “Tor Vergata”, I-00133 Rome, Italy; [email protected] (B.M.); [email protected] (P.C.) 4 Child Psychopathology Unit, Scientific Institute, IRCCS ‘E. Medea’, I-23842 Bosisio Parini (LC), Italy; [email protected] (M.N.); [email protected] (C.R.); [email protected] (M.M.) 5 Interdepartmental Program “Autism 0–90”, “G. Martino” University Hospital, University of Messina, I-98122 Messina, Italy * Correspondence: [email protected] Abstract: Organophosphate compounds (OPs) interfere with neurodevelopment and are neuro- toxic for humans and animals. They are first biotransformed to the more toxic oxon form, and then hydrolyzed to specific metabolites by the enzyme paraoxonase/arylesterase, encoded by the gene PON1 located on human chr. 7q21.3. In autism spectrum disorder (ASD) and in attention- deficit/hyperactivity disorder (ADHD), a correlation between OP exposure and disease onset has Citation: Piras, I.S.; Gabriele, S.; been reported. -
Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum
Int. J. Environ. Res. Public Health 2014, 11, 1422-1443; doi:10.3390/ijerph110201422 OPEN ACCESS International Journal of Environmental Research and Public Health ISSN 1660-4601 www.mdpi.com/journal/ijerph Article Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum 1, 2,3 1 Yutaka Aoki *, Kathy J. Helzlsouer and Paul T. Strickland 1 Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; E-Mail: [email protected] 2 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA 3 Mercy Medical Center, Baltimore, MD 21202, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed: E-Mail: [email protected]; Tel.: +1-410-404-9153. Received: 3 June 2013; in revised form: 27 December 2013 / Accepted: 15 January 2014 / Published: 27 January 2014 Abstract: Context: Cholinesterase (ChE) specific activity is the ratio of ChE activity to ChE mass and, as a biomarker of exposure to cholinesterase inhibitors, has a potential advantage over simple ChE activity. Objective: To examine the association of several potential correlates (serum arylesterase/paraoxonase activity, serum albumin, sex, age, month of blood collection, and smoking) with plasma ChE specific activity. Methods: We analyzed data from 195 cancer-free controls from a nested case-control study, accounting for potential confounding. Results: Arylesterase activity had an independent, statistically significant positive association with ChE specific activity, and its magnitude was the greatest for the arylesterase phenotype corresponding to the QQ PON1192 genotype followed by phenotypes corresponding to QR and RR genotypes.